Canine Osteomyelitis Study Guide

Overview and Clinical Importance

Osteomyelitis is inflammation and infection of bone and bone marrow, representing a significant challenge in small animal orthopedics. This condition can result from trauma, surgery, or hematogenous spread of infection, with potential for serious complications including chronic pain, limb dysfunction, and even septicemia.

Osteomyelitis is frequently tested on the NAVLE because it requires understanding of microbiology, pathophysiology, diagnostic imaging, and both medical and surgical management. The incidence has been reported as high as 31% of canine fracture repairs, making it a clinically relevant topic for veterinary practice.

Classification of Osteomyelitis

Osteomyelitis is classified based on route of infection and duration of disease. Understanding these classifications is essential for determining appropriate treatment strategies.

Classification by Route of Infection

Hematogenous Osteomyelitis

Hematogenous osteomyelitis results from bacterial seeding via the bloodstream. This form is more common in juvenile animals due to metaphyseal vascular anatomy featuring end-arterial hairpin loops with slow blood flow, providing an ideal environment for bacterial colonization.

In adult dogs, hematogenous osteomyelitis is rare and typically affects immunocompromised animals or those with concurrent systemic infections such as septicemia, urinary tract infections, or dental disease.

Post-Traumatic (Exogenous) Osteomyelitis

Post-traumatic osteomyelitis is the most common form in dogs, resulting from direct inoculation of bacteria into bone. Common causes include open fractures, bite wounds, gunshot injuries, and contamination during orthopedic surgery.

Damaged blood supply and tissue necrosis at the site of trauma create an environment conducive to bacterial proliferation. The incidence of post-traumatic osteomyelitis following fracture repair ranges from 0.4% to 31% depending on fracture type and surgical technique.

Iatrogenic Osteomyelitis

Iatrogenic osteomyelitis occurs secondary to orthopedic procedures including fracture repair, joint replacement, or bone biopsy. Risk factors include prolonged surgical time, contaminated implants, compromised aseptic technique, and presence of foreign material.

Classification by Duration

Acute Osteomyelitis

Acute osteomyelitis develops rapidly over days to weeks, characterized by purulent inflammation, edema, vascular congestion, and neutrophilic infiltration. Clinical signs include fever, lameness, pain, and local swelling.

Chronic Osteomyelitis

Chronic osteomyelitis persists for weeks to months and is characterized by bone sequestration, draining fistulous tracts, irregular periosteal reaction, and resistant infection often involving biofilm formation. Histopathology reveals mononuclear cell infiltration and necrotic bone.

Etiology and Pathogenesis

Common Bacterial Pathogens

Staphylococcus species account for approximately 50% of canine osteomyelitis cases. Staphylococcus intermedius (now reclassified as Staphylococcus pseudintermedius) is most common in dogs, while Staphylococcus aureus is more frequent in cats.

Fungal Osteomyelitis

Fungal osteomyelitis typically results from hematogenous spread following pulmonary inoculation. Geographic distribution is important for diagnosis:

Coccidioides immitis: Southwestern United States (Arizona, California, Texas, New Mexico)

Blastomyces dermatitidis: Mississippi, Ohio, and Missouri River valleys; Great Lakes region

Histoplasma capsulatum: Central United States, especially Mississippi and Ohio River valleys

Cryptococcus neoformans: Worldwide distribution, associated with pigeon droppings

Bone lesions occur in approximately 15-30% of dogs with systemic blastomycosis and commonly involve the appendicular skeleton, particularly distal to the elbow or stifle. Radiographically, fungal osteomyelitis causes severe osteolysis with aggressive periosteal proliferation.

Pathophysiology and Biofilm Formation

The pathogenesis of osteomyelitis involves several key steps. Initially, bacteria adhere to bone or implant surfaces through adhesins and surface proteins. Biofilm formation is a critical factor in chronic infection, where bacteria produce a protective glycocalyx that shields them from host immune responses and antibiotics.

Reduced blood flow from trauma or surgery impairs delivery of immune cells and antibiotics to infected tissue. Bacterial toxins and inflammatory mediators cause bone necrosis, creating sequestra (dead bone fragments) that serve as a nidus for persistent infection. The body responds by forming an involucrum (reactive new bone) around the sequestrum.

Memory Aid - 'BIOFILM' for Chronic Osteomyelitis: B-Bacterial glycocalyx, I-Implant colonization, O-Osteolysis, F-Fistulous tracts, I-Involucrum formation, L-Loosening of hardware, M-Multiple organisms possible.

Clinical Presentation

Acute Osteomyelitis

Dogs with acute osteomyelitis typically present with:

Systemic Signs: Fever (pyrexia), anorexia, depression, lethargy

Localized Signs: Lameness (often non-weight bearing), pain on palpation of affected bone, swelling, heat, edema

Wound-Related: Purulent discharge, delayed wound healing, dehiscence

Chronic Osteomyelitis

Chronic osteomyelitis may present with minimal systemic signs:

Persistent lameness: Variable weight-bearing, intermittent improvement with antibiotics

Draining tracts: Chronic sinus formation with purulent or serosanguineous discharge

Muscle atrophy: Disuse atrophy of limb musculature

Loose implants: Palpable movement of fracture fixation devices

Pain: Localized bone pain, reduced range of motion

Location-Specific Presentations

Long Bones: Most common site; lameness, swelling, pain

Mandibular/Maxillary: Often secondary to dental disease; facial swelling, pain on eating, halitosis, draining tracts

Vertebral (Diskospondylitis): Back pain, hindlimb weakness, difficulty rising, neurologic deficits

Diagnostic Approach

Clinical Pathology

Complete Blood Count

Acute osteomyelitis: Leukocytosis with left shift (neutrophilia), toxic neutrophils possible

Chronic osteomyelitis: Often normal WBC or mild elevation; may see anemia of chronic disease

Serum Biochemistry

Usually unremarkable; may show mild hyperglobulinemia in chronic cases

Inflammatory Markers

C-reactive protein: Elevated in acute bacterial infection

Erythrocyte sedimentation rate: May be elevated but nonspecific

Microbiological Diagnosis

Bacterial Culture and Sensitivity

Gold standard for diagnosis. Collect deep tissue samples or bone biopsies, not superficial swabs. Submit 5 or more samples to increase diagnostic yield.

Important: Withhold antibiotics for at least 2 weeks before sampling in chronic cases to avoid false negatives. In acute cases with systemic signs, sample before starting empirical therapy.

Blood Cultures

Indicated in suspected hematogenous osteomyelitis. Collect during febrile episodes before antibiotic administration. Positive blood cultures may eliminate need for bone biopsy if radiographic evidence supports osteomyelitis.

Cytology

Fine-needle aspiration or impression smears from deep tissue show degenerate neutrophils with intracellular bacteria. Provides rapid preliminary diagnosis while awaiting culture results.

Diagnostic Imaging

Radiography

First-line imaging modality. Radiographic changes lag behind clinical signs:

Acute osteomyelitis (5-14 days): Soft tissue swelling, periosteal reaction (new bone formation), subtle bone lucency

Chronic osteomyelitis (weeks-months): Bone lysis (moth-eaten or permeative pattern), sequestrum (dense bone fragment), involucrum (surrounding reactive bone), irregular periosteal reaction, cortical destruction, implant loosening

Advanced Imaging

Computed Tomography (CT): Superior for detecting early bone changes, sequestra, and extent of disease. Useful for surgical planning.

Magnetic Resonance Imaging (MRI): Excellent for evaluating soft tissue involvement, bone marrow edema, and abscess formation. More sensitive than radiography in early disease.

Nuclear Scintigraphy: Highly sensitive for detecting early osteomyelitis and multifocal disease. Uptake of technetium-99m methylene diphosphonate indicates increased bone turnover.

Ultrasonography: Can identify subperiosteal abscesses and soft tissue involvement. Limited for evaluating bone structure.

Differential Diagnoses

Conditions that may mimic osteomyelitis radiographically and clinically include:

Neoplasia: Primary bone tumors (osteosarcoma, chondrosarcoma) or metastatic disease

Hypertrophic Osteodystrophy (HOD): Young, rapidly growing dogs; bilateral metaphyseal lesions

Panosteitis: Young large-breed dogs; self-limiting; shifting leg lameness; intramedullary sclerosis

Chronic Recurrent Multifocal Osteomyelitis (CRMO): Rare sterile inflammatory bone disease in young dogs

Septic Arthritis: Can co-exist with osteomyelitis or occur independently

Treatment

Successful management of osteomyelitis requires combined medical and surgical approaches.

Medical Management

Empirical Antibiotic Therapy

For acute cases with systemic signs, initiate broad-spectrum bactericidal antibiotics immediately after obtaining culture samples. Choose beta-lactamase resistant agents due to high prevalence of Staphylococcus.

Culture-Directed Antibiotic Therapy

For chronic osteomyelitis without acute systemic signs, await culture results before starting antibiotics to prevent development of resistant organisms. Adjust therapy based on minimum inhibitory concentration (MIC) values.

Duration of Antibiotic Therapy

Minimum 4-8 weeks of antibiotics required. Continue therapy for at least 2 weeks beyond clinical resolution and radiographic evidence of healing. Chronic refractory cases may require 3-6 months or longer.

Antifungal Therapy

For fungal osteomyelitis, long-term antifungal therapy is required:

Itraconazole: 5-10 mg/kg PO q12-24h; first-line for blastomycosis and coccidioidomycosis

Fluconazole: 5-10 mg/kg PO q12-24h; good for cryptococcosis

Duration: Minimum 2-4 months; treat at least 1 month beyond clinical resolution

Supportive Care

Analgesia: NSAIDs (carprofen, meloxicam) or opioids (tramadol, buprenorphine) for pain management

Nutrition: High-quality protein to support immune function and tissue healing

Activity Restriction: Strict cage rest or limited leash walks to prevent pathologic fracture

Surgical Management

Surgical intervention is often necessary, especially for chronic osteomyelitis:

Debridement and Lavage

Aggressive surgical debridement removes necrotic tissue, sequestra, and biofilm. Copious lavage with sterile saline or antiseptic solutions (dilute chlorhexidine, povidone-iodine) reduces bacterial load.

Implant Removal

Remove loose or infected implants. Foreign material serves as nidus for biofilm formation. If fracture is healed, remove all hardware. If fracture is unstable, consider external skeletal fixation after implant removal.

Sequestrectomy

Surgical removal of sequestra (dead bone fragments) is essential. Sequestra lack blood supply, preventing antibiotic penetration and serving as bacterial reservoir.

Bone Grafting

After infection control, autogenous cancellous bone grafting fills defects, provides osteogenic cells, and promotes healing. Delayed grafting (weeks to months after debridement) reduces risk of graft infection.

Drainage Systems

Open drainage: Allows continued egress of purulent material; requires intensive wound management

Closed suction drainage: Penrose or Jackson-Pratt drains evacuate fluid while maintaining wound closure

Local Antibiotic Delivery

Antibiotic-impregnated polymethylmethacrylate (PMMA) beads or biodegradable polymers deliver high local antibiotic concentrations. Commonly used antibiotics include gentamicin, tobramycin, or amikacin. PMMA beads require second surgery for removal.

Amputation

For chronic, refractory cases with extensive bone destruction, severe pain, or failed medical and surgical management, limb amputation may be indicated. Most dogs adapt well to three-legged ambulation.

Memory Aid - 'DRAIN' for Surgical Management: D-Debridement, R-Remove implants, A-Aggressive lavage, I-Isolate sequestra (sequestrectomy), N-New bone graft (delayed).

Prognosis and Complications

Prognosis

Prognosis varies significantly based on:

Acute osteomyelitis: Favorable prognosis (greater than 90% success) with early aggressive treatment

Chronic osteomyelitis: Guarded prognosis; recurrence common; may require multiple surgeries

Implant-associated: Guarded until implant removal; improved after hardware extraction

Fungal osteomyelitis: Guarded to poor; often requires prolonged (months to years) therapy

Complications

Pathologic Fracture: Bone weakening from lysis; requires stabilization

Chronic Pain: Persistent discomfort requiring long-term analgesia

Septicemia: Systemic spread of infection; life-threatening

Antibiotic Resistance: Development of resistant organisms from inappropriate therapy

Recurrence: Return of infection after apparent resolution

Neoplastic Transformation: Rare; squamous cell carcinoma may develop at chronic draining sites

Amyloidosis: Long-term chronic inflammation may lead to secondary amyloidosis